{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:47Z","timestamp":1790833367130,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18271-9","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:48:10Z","timestamp":1758808090000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lysosome-related molecular subtypes reveal prognostic signatures and immunotherapeutic implications in ovarian cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhou","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"issue":"3","key":"18271_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"18271_CR2","doi-asserted-by":"crossref","unstructured":"Siegel, R. L., Giaquinto, A. N., & Jemal, A.  Cancer statistics CA A Cancer J. Clin. 74(1), 12\u201349 (2024).","DOI":"10.3322\/caac.21820"},{"issue":"10177","key":"18271_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux, S., Gourley, C., Vergote, I. & Oza, A. M. Epithelial ovarian cancer. Lancet 393 (10177), 1240\u20131253 (2019).","journal-title":"Lancet"},{"issue":"9","key":"18271_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ncb0905-847","volume":"7","author":"C de Duve","year":"2005","unstructured":"de Duve, C. The lysosome turns Fifty. Nat. Cell. Biol. 7 (9), 847\u2013849 (2005).","journal-title":"Nat. Cell. Biol."},{"key":"18271_CR5","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-cellbio-111315-125125","volume":"32","author":"RM Perera","year":"2016","unstructured":"Perera, R. M. & Zoncu, R. The lysosome as a regulatory hub. Annu. Rev. Cell. Dev. Biol. 32, 223\u2013253 (2016).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"16","key":"18271_CR6","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/onc.2012.292","volume":"32","author":"T Kallunki","year":"2013","unstructured":"Kallunki, T., Olsen, O. D. & J\u00e4\u00e4ttel\u00e4, M. Cancer-associated lysosomal changes: friends or foes? Oncogene 32 (16), 1995\u20132004 (2013).","journal-title":"Oncogene"},{"key":"18271_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1146\/annurev-pharmtox-010715-103101","volume":"57","author":"SM Davidson","year":"2017","unstructured":"Davidson, S. M. & Vander Heiden, M. G. Critical functions of the lysosome in cancer biology. Annu. Rev. Pharmacol. Toxicol. 57, 481\u2013507 (2017).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"18271_CR8","doi-asserted-by":"crossref","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012) (Erratum in: Cancer Discov 2012;2:960).","DOI":"10.1158\/2159-8290.CD-12-0095"},{"issue":"5","key":"18271_CR9","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-11-2725","volume":"18","author":"K Yoshihara","year":"2012","unstructured":"Yoshihara, K. et al. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Clin. Cancer Res. 18 (5), 1374\u20131385. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2725 (2012).","journal-title":"Clin. Cancer Res."},{"key":"18271_CR10","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"18271_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33, 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"key":"18271_CR12","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1002\/sim.5958","volume":"32","author":"P Blanche","year":"2013","unstructured":"Blanche, P., Dartigues, J. F. & Jacqmin-Gadda, H. Estimating and comparing time-dependent areas under receiver operating characteristic curves for censored event times with competing risks. Stat. Med. 32, 5381\u20135397 (2013).","journal-title":"Stat. Med."},{"key":"18271_CR13","unstructured":"Harrell, F. E. Jr. _rms: Regression Modeling Strategies_. R package version 6.5-0. Available online: (2023). https:\/\/CRAN.R-project.org\/package=rms."},{"key":"18271_CR14","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu, T. et al. ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov. (Camb). 2, 100141 (2021).","journal-title":"Innov. (Camb)"},{"key":"18271_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"18271_CR16","doi-asserted-by":"publisher","first-page":"180015","DOI":"10.1038\/sdata.2018.15","volume":"5","author":"S Bhattacharya","year":"2018","unstructured":"Bhattacharya, S. et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci. Data. 5, 180015 (2018).","journal-title":"Sci. Data"},{"issue":"8","key":"18271_CR17","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/s41588-022-01141-9","volume":"54","author":"D Barkley","year":"2022","unstructured":"Barkley, D. et al. Cancer cell States recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 54 (8), 1192\u20131201 (2022).","journal-title":"Nat. Genet."},{"key":"18271_CR18","unstructured":"Yoshihara, K., Kim, H. & Verhaak, R. G. _estimate: estimate of stromal and immune cells in malignant tumor tissues from expression data_. R package version 1.0.13\/r21. Available online: (2016). https:\/\/R-Forge.R-project.org\/projects\/estimate\/."},{"key":"18271_CR19","unstructured":"Maeser, D. _oncoPredict: Drug and Biomarker Discovery_. R package version 0.2. Available online: (2021). https:\/\/CRAN.R-project.org\/package=oncoPredict."},{"key":"18271_CR20","unstructured":"Gao, Z. J. Integrative multi-omics Analyses Unravel the Immunological Implication and Prognostic Significance of CXCL12 in Breast Cancer. Front. Immunol."},{"issue":"5","key":"18271_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24 (5), 541\u2013550 (2018).","journal-title":"Nat. Med."},{"issue":"8","key":"18271_CR22","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.7150\/thno.96163","volume":"14","author":"ZJ Gao","year":"2024","unstructured":"Gao, Z. J. et al. Single-cell analyses reveal evolution mimicry during the specification of breast cancer subtype. Theranostics 14 (8), 3104\u20133126 (2024).","journal-title":"Theranostics"},{"issue":"5","key":"18271_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41419-022-04912-8","volume":"13","author":"T Iulianna","year":"2022","unstructured":"Iulianna, T., Kuldeep, N. & Eric, F. The achilles\u2019 heel of cancer: targeting tumors via lysosome-induced Immunogenic cell death. Cell. Death Dis. 13 (5), 509 (2022).","journal-title":"Cell. Death Dis."},{"issue":"2","key":"18271_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1042\/BST20170130","volume":"46","author":"A Serrano-Puebla","year":"2018","unstructured":"Serrano-Puebla, A. & Boya, P. Lysosomal membrane permeabilization as a cell death mechanism in cancer cells. Biochem. Soc. Trans. 46 (2), 207\u2013215 (2018).","journal-title":"Biochem. Soc. Trans."},{"key":"18271_CR25","doi-asserted-by":"publisher","first-page":"1384633","DOI":"10.3389\/fimmu.2024.1384633","volume":"15","author":"P Wan","year":"2024","unstructured":"Wan, P. et al. Lysosome-related genes predict acute myeloid leukemia prognosis and response to immunotherapy. Front. Immunol. 15, 1384633 (2024).","journal-title":"Front. Immunol."},{"key":"18271_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","volume":"13","author":"V Mittal","year":"2018","unstructured":"Mittal, V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395\u2013412 (2018).","journal-title":"Annu. Rev. Pathol."},{"issue":"8","key":"18271_CR27","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler, F. et al. Cancer neuroscience: state of the field, emerging directions. Cell 186 (8), 1689\u20131707 (2023).","journal-title":"Cell"},{"key":"18271_CR28","doi-asserted-by":"crossref","unstructured":"Holicek, P. et al. Type I interferon and cancer. Immunol. Rev. ; (2023).","DOI":"10.1111\/imr.13272"},{"issue":"1","key":"18271_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13045-021-01103-4","volume":"14","author":"T Fu","year":"2021","unstructured":"Fu, T. et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J. Hematol. Oncol. 14 (1), 98 (2021).","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"18271_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41419-018-0352-0","volume":"9","author":"ST Yu","year":"2018","unstructured":"Yu, S. T. et al. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK\/ERK and PI3K\/AKT pathways. Cell. Death Dis. 9 (3), 371 (2018).","journal-title":"Cell. Death Dis."},{"key":"18271_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3389\/fendo.2020.00535","volume":"11","author":"ST Yu","year":"2020","unstructured":"Yu, S. T. et al. CRLF1-MYH9 interaction regulates proliferation and metastasis of papillary thyroid carcinoma through the ERK\/ETV4 axis. Front. Endocrinol. (Lausanne). 11, 535 (2020).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"18271_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1186\/s12967-021-03102-y","volume":"19","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. miR-3065-3p promotes stemness and metastasis by targeting CRLF1 in colorectal cancer. J. Transl Med. 19 (1), 429 (2021).","journal-title":"J. Transl Med."},{"issue":"5","key":"18271_CR33","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/sj.bjc.6603918","volume":"97","author":"V Minas","year":"2007","unstructured":"Minas, V. et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. Br. J. Cancer. 97 (5), 637\u2013645 (2007).","journal-title":"Br. J. Cancer"},{"issue":"11","key":"18271_CR34","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1002\/mc.22691","volume":"56","author":"X Fang","year":"2017","unstructured":"Fang, X. et al. CRH promotes human colon cancer cell proliferation via IL-6\/JAK2\/STAT3 signaling pathway and VEGF-induced tumor angiogenesis. Mol. Carcinog. 56 (11), 2434\u20132445 (2017).","journal-title":"Mol. Carcinog."},{"issue":"11","key":"18271_CR35","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.trecan.2020.06.005","volume":"6","author":"V Ramesh","year":"2020","unstructured":"Ramesh, V., Brabletz, T. & Ceppi, P. Targeting EMT in cancer with repurposed metabolic inhibitors. Trends Cancer. 6 (11), 942\u2013950 (2020).","journal-title":"Trends Cancer"},{"issue":"10","key":"18271_CR36","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/s41401-022-00894-7","volume":"43","author":"S Li","year":"2022","unstructured":"Li, S. et al. ADH1C inhibits progression of colorectal cancer through the ADH1C\/PHGDH \/PSAT1\/serine metabolic pathway. Acta Pharmacol. Sin. 43 (10), 2709\u20132722 (2022).","journal-title":"Acta Pharmacol. Sin"},{"key":"18271_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fgene.2020.00369","volume":"11","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y., Zhang, Z., Jiang, Z., Liu, Y. & Zhou, J. CD38 predicts favorable prognosis by enhancing immune infiltration and antitumor immunity in the epithelial ovarian cancer microenvironment. Front. Genet. 11, 369 (2020).","journal-title":"Front. Genet."},{"issue":"1","key":"18271_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","volume":"8","author":"S Chen","year":"2023","unstructured":"Chen, S. et al. Macrophages in immunoregulation and therapeutics. Signal. Transduct. Target. Ther. 8 (1), 207 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"4","key":"18271_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.trecan.2022.12.007","volume":"9","author":"N Guti\u00e9rrez-Melo","year":"2023","unstructured":"Guti\u00e9rrez-Melo, N. & Baumjohann, D. T follicular helper cells in cancer. Trends Cancer. 9 (4), 309\u2013325 (2023).","journal-title":"Trends Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18271-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18271-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:48:13Z","timestamp":1758808093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18271-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18271"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18271-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32898"}}